Palivizumab prophylaxis in haemodynamically significant congenital heart disease
- PMID: 16040889
- PMCID: PMC1720529
- DOI: 10.1136/adc.2004.069948
Palivizumab prophylaxis in haemodynamically significant congenital heart disease
Comment on
-
Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease.Arch Dis Child. 2004 Oct;89(10):961-5. doi: 10.1136/adc.2003.046714. Arch Dis Child. 2004. PMID: 15383442 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical